STE vs. BSX

Last updated Apr 1, 2026

Compare and contrast key facts about STERIS plc (STE) and Boston Scientific Corporation (BSX).

Performance

STE vs. BSX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in STERIS plc (STE) and Boston Scientific Corporation (BSX). The values are adjusted to include any dividend payments, if applicable.

STE vs. BSX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
STE STERIS plc	-12.55%	24.57%	-5.60%	20.19%	-23.43%	29.47%	25.50%	44.09%	23.66%	31.73%
BSX Boston Scientific Corporation	-34.19%	6.75%	54.51%	24.94%	8.92%	18.16%	-20.50%	27.96%	42.56%	14.61%

Fundamentals

Market Cap STE : $21.85B BSX : $93.86B
EPS STE : $7.16 BSX : $1.93
PE Ratio STE : 30.87 BSX : 32.46
PEG Ratio STE : 0.57 BSX : 0.73
PS Ratio STE : 3.75 BSX : 4.67
PB Ratio STE : 3.05 BSX : 3.87
Total Revenue (TTM) STE : $5.83B BSX : $20.08B
Gross Profit (TTM) STE : $2.57B BSX : $13.85B
EBITDA (TTM) STE : $1.36B BSX : $4.91B

Returns By Period

In the year-to-date period, STE achieves a -12.55% return, which is significantly higher than BSX's -34.19% return. Both investments have delivered pretty close results over the past 10 years, with STE having a 13.04% annualized return and BSX not far behind at 12.73%.

STE

• 1D: 0.80%
• 1M: -12.37%
• YTD: -12.55%
• 6M: -10.19%
• 1Y: -1.46%
• 3Y*: 5.98%
• 5Y*: 3.67%
• 10Y*: 13.04%

BSX

• 1D: -0.29%
• 1M: -18.35%
• YTD: -34.19%
• 6M: -35.73%
• 1Y: -37.80%
• 3Y*: 7.84%
• 5Y*: 10.22%
• 10Y*: 12.73%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

STE vs. BSX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

STE

STE Risk / Return Rank: 38
STE Sharpe Ratio Rank: 39
STE Sortino Ratio Rank: 33
STE Omega Ratio Rank: 32
STE Calmar Ratio Rank: 42
STE Martin Ratio Rank: 42

BSX

BSX Risk / Return Rank: 4
BSX Sharpe Ratio Rank: 2
BSX Sortino Ratio Rank: 5
BSX Omega Ratio Rank: 3
BSX Calmar Ratio Rank: 9
BSX Martin Ratio Rank: 0

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

STE vs. BSX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for STERIS plc (STE) and Boston Scientific Corporation (BSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	STE	BSX	Difference
Sharpe ratio Return per unit of total volatility	-0.06	-1.21	+1.16
Sortino ratio Return per unit of downside risk	0.11	-1.59	+1.69
Omega ratio Gain probability vs. loss probability	1.01	0.75	+0.26
Calmar ratio Return relative to maximum drawdown	0.01	-0.88	+0.89
Martin ratio Return relative to average drawdown	0.02	-2.47	+2.49
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

STE vs. BSX - Sharpe Ratio Comparison

The current STE Sharpe Ratio is -0.06, which is higher than the BSX Sharpe Ratio of -1.21. The chart below compares the historical Sharpe Ratios of STE and BSX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	STE	BSX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.06	-1.21	+1.16
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.14	0.42	-0.28
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.52	0.48	+0.05
Sharpe Ratio (All Time) Calculated using the full available price history	0.42	0.22	+0.20

Correlation

The correlation between STE and BSX is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

STE vs. BSX - Dividend Comparison

STE's dividend yield for the trailing twelve months is around 1.11%, while BSX has not paid dividends to shareholders.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
STE STERIS plc	1.11%	0.95%	1.06%	0.90%	0.97%	0.68%	0.81%	0.93%	1.22%	1.35%	1.57%	1.27%
BSX Boston Scientific Corporation	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Drawdowns

STE vs. BSX - Drawdown Comparison

The maximum STE drawdown since its inception was -77.22%, smaller than the maximum BSX drawdown of -89.15%. Use the drawdown chart below to compare losses from any high point for STE and BSX.

Drawdown Indicators

	STE	BSX	Difference
Max Drawdown Largest peak-to-trough decline	-77.22%	-89.15%	+11.93%
Max Drawdown (1Y) Largest decline over 1 year	-20.76%	-41.97%	+21.21%
Max Drawdown (5Y) Largest decline over 5 years	-36.18%	-41.97%	+5.79%
Max Drawdown (10Y) Largest decline over 10 years	-36.18%	-43.49%	+7.31%
Current Drawdown Current decline from peak	-17.48%	-41.97%	+24.49%
Average Drawdown Average peak-to-trough decline	-18.32%	-38.71%	+20.39%
Ulcer Index Depth and duration of drawdowns from previous peaks	6.80%	14.94%	-8.14%

Volatility

STE vs. BSX - Volatility Comparison

The current volatility for STERIS plc (STE) is 7.48%, while Boston Scientific Corporation (BSX) has a volatility of 11.48%. This indicates that STE experiences smaller price fluctuations and is considered to be less risky than BSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	STE	BSX	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.48%	11.48%	-4.00%
Volatility (6M) Calculated over the trailing 6-month period	17.83%	27.07%	-9.24%
Volatility (1Y) Calculated over the trailing 1-year period	25.59%	31.31%	-5.72%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	25.62%	24.21%	+1.41%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	24.97%	26.76%	-1.79%

Financials

STE vs. BSX - Profitability Comparison

The chart below illustrates the profitability comparison between STERIS plc and Boston Scientific Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

STE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, STERIS plc reported a gross profit of 655.50M and revenue of 1.50B. Therefore, the gross margin over that period was 43.8%.

BSX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Boston Scientific Corporation reported a gross profit of 3.94B and revenue of 5.29B. Therefore, the gross margin over that period was 74.5%.

STE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, STERIS plc reported an operating income of 271.00M and revenue of 1.50B, resulting in an operating margin of 18.1%.

BSX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Boston Scientific Corporation reported an operating income of 1.21B and revenue of 5.29B, resulting in an operating margin of 22.8%.

STE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, STERIS plc reported a net income of 192.80M and revenue of 1.50B, resulting in a net margin of 12.9%.

BSX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Boston Scientific Corporation reported a net income of 668.00M and revenue of 5.29B, resulting in a net margin of 12.6%.